Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $1,449,667 (100.0% shares, 0.0% debt)

Holdings (35)

ASML ASML HOLDING N V 12.2%
Value ($000) $177,146 Shares 182,536 Est. Cost $654.82 Unrealized
BN BROOKFIELD CORP 11.2%
Value ($000) $162,465 Shares 3,880,230 Est. Cost $22.16 Unrealized +20.2%
CRM SALESFORCE INC 10.0%
Value ($000) $144,615 Shares 480,160 Est. Cost $193.03 Unrealized +47.7%
EPC EDGEWISE THERAPEUTICS INC 8.0%
Value ($000) $115,722 Shares 6,344,430 Est. Cost $36.27 Unrealized 0.0%
CORT CORCEPT THERAPEUTICS INC 4.2%
Value ($000) $60,742 Shares 2,411,362 Est. Cost $23.02 Unrealized +2.7%
PCVX VAXCYTE INC 4.0%
Value ($000) $57,722 Shares 845,000 Est. Cost $26.47 Unrealized +161.6%
CRNX CRINETICS PHARMACEUTICALS IN 3.5%
Value ($000) $51,425 Shares 1,098,600 Est. Cost $19.36 Unrealized +102.1%
CABO CABLE ONE INC 3.5%
Value ($000) $50,100 Shares 118,403 Est. Cost $987.67 Unrealized -52.0%
LANZATECH GLOBAL INC 3.4%
Value ($000) $48,947 Shares 15,814,845 Est. Cost $3.88 Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 3.1%
Value ($000) $44,604 Shares 1,400,000 Est. Cost $17.62 Unrealized +44.8%
BMRN BIOMARIN PHARMACEUTICAL INC 2.7%
Value ($000) $39,303 Shares 450,000 Est. Cost $84.31 Unrealized +6.2%
MIRM MIRUM PHARMACEUTICALS INC 2.6%
Value ($000) $37,680 Shares 1,500,000 Est. Cost $12.27 Unrealized +124.1%
INSM INSMED INC 2.5%
Value ($000) $36,335 Shares 1,339,304 Est. Cost $23.10 Unrealized +21.1%
BABA ALIBABA GROUP HLDG LTD 2.5%
Value ($000) $36,240 Shares 500,827 Est. Cost $165.09 Unrealized
BLUEPRINT MEDICINES CORP 2.3%
Value ($000) $34,019 Shares 358,626 Est. Cost $59.75 Unrealized
AAPL APPLE INC 2.2%
Value ($000) $31,374 Shares 182,960 Est. Cost $90.57 Unrealized +99.0%
FOLD AMICUS THERAPEUTICS INC 2.0%
Value ($000) $29,450 Shares 2,500,000 Est. Cost $12.83 Unrealized -0.3%
RCKT ROCKET PHARMACEUTICALS INC 2.0%
Value ($000) $28,287 Shares 1,050,000 Est. Cost $28.33 Unrealized +0.3%
CARGO THERAPEUTICS INC 1.9%
Value ($000) $27,900 Shares 1,250,000 Est. Cost $23.15 Unrealized
PHVS PHARVARIS N V 1.9%
Value ($000) $26,993 Shares 1,168,030 Est. Cost $12.83 Unrealized +107.0%
VERVE THERAPEUTICS INC 1.8%
Value ($000) $26,560 Shares 2,000,000 Est. Cost $13.94 Unrealized
BAM BROOKFIELD ASSET MANAGMT LTD 1.8%
Value ($000) $26,355 Shares 627,207 Est. Cost $31.11 Unrealized +22.0%
LXEO LEXEO THERAPEUTICS INC 1.8%
Value ($000) $25,689 Shares 1,638,298 Est. Cost $13.07 Unrealized +19.6%
VRDN VIRIDIAN THERAPEUTICS INC 1.3%
Value ($000) $19,261 Shares 1,100,000 Est. Cost $19.39 Unrealized 0.0%
AVBP ARRIVENT BIOPHARMA INC 1.3%
Value ($000) $19,238 Shares 1,077,140 Est. Cost $20.17 Unrealized 0.0%
MGX METAGENOMI INC 1.3%
Value ($000) $18,348 Shares 1,739,175 Est. Cost $11.50 Unrealized 0.0%
ALNY ALNYLAM PHARMACEUTICALS INC 1.2%
Value ($000) $17,692 Shares 118,383 Est. Cost $160.04 Unrealized +4.2%
KYTX KYVERNA THERAPEUTICS INC 1.2%
Value ($000) $17,388 Shares 700,000 Est. Cost $27.84 Unrealized 0.0%
INSP INSPIRE MED SYS INC 1.0%
Value ($000) $14,074 Shares 65,524 Est. Cost $202.35 Unrealized -3.1%
IOBT IO BIOTECH INC 0.6%
Value ($000) $8,803 Shares 5,088,258 Est. Cost $6.26 Unrealized -72.3%
ABCL ABCELLERA BIOLOGICS INC 0.4%
Value ($000) $5,105 Shares 1,126,915 Est. Cost $8.47 Unrealized -39.7%
TMCI TREACE MED CONCEPTS INC 0.3%
Value ($000) $4,698 Shares 360,000 Est. Cost $25.28 Unrealized -47.3%
MQ MARQETA INC 0.2%
Value ($000) $2,632 Shares 441,558 Est. Cost $22.37 Unrealized -72.3%
GALECTO INC 0.1%
Value ($000) $1,948 Shares 2,497,791 Est. Cost $12.51 Unrealized
SPRO SPERO THERAPEUTICS INC 0.1%
Value ($000) $807 Shares 468,902 Est. Cost $11.41 Unrealized -86.3%